TCL Archive Tarceva-Induced Rash Strongly Associated With Longer Survival, Sponsor Finds July 27, 2007
TCL Archive FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug July 26, 2013